loratadine has been researched along with Gastritis in 3 studies
Loratadine: A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
loratadine : A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.
Gastritis: Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Findings were conclusive with subserosal type of eosinophilic gastroenteritis and the patient's treatment started with a combination of parenteral methylprednisolone and oral loratadine." | 7.79 | Enhanced therapeutic response with addition of loratadine in subserosal eosinophilic gastroenteritis. ( Alibegović, E; Jovanović, P; Mustedanagić-Mujanović, J; Salkić, NN, 2013) |
| " Findings were conclusive with subserosal type of eosinophilic gastroenteritis and the patient's treatment started with a combination of parenteral methylprednisolone and oral loratadine." | 3.79 | Enhanced therapeutic response with addition of loratadine in subserosal eosinophilic gastroenteritis. ( Alibegović, E; Jovanović, P; Mustedanagić-Mujanović, J; Salkić, NN, 2013) |
| "Loratadine is an anti-histamine routinely used for treating allergies." | 1.72 | Anti-Inflammatory Activities of an Anti-Histamine Drug, Loratadine, by Suppressing TAK1 in AP-1 Pathway. ( Cho, JY; Hunto, ST; Jang, J; Kim, HG; Kim, JW; Lee, HP, 2022) |
| "Loratadine is an antihistamine drug that shows promise as an anti-inflammatory drug, but supportive studies are lacking." | 1.56 | Loratadine, an antihistamine drug, exhibits anti-inflammatory activity through suppression of the NF- ( Baek, KS; Cho, JY; Hunto, ST; Jeong, D; Kim, E; Kim, HG; Kim, JH, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Jang, J | 1 |
| Hunto, ST | 2 |
| Kim, JW | 1 |
| Lee, HP | 1 |
| Kim, HG | 2 |
| Cho, JY | 2 |
| Baek, KS | 1 |
| Jeong, D | 1 |
| Kim, E | 1 |
| Kim, JH | 1 |
| Salkić, NN | 1 |
| Mustedanagić-Mujanović, J | 1 |
| Jovanović, P | 1 |
| Alibegović, E | 1 |
3 other studies available for loratadine and Gastritis
| Article | Year |
|---|---|
Anti-Inflammatory Activities of an Anti-Histamine Drug, Loratadine, by Suppressing TAK1 in AP-1 Pathway.
Topics: Animals; Anti-Inflammatory Agents; Gastritis; Histamine Antagonists; Loratadine; Mice; RAW 264.7 Cel | 2022 |
Loratadine, an antihistamine drug, exhibits anti-inflammatory activity through suppression of the NF-
Topics: Animals; Anti-Inflammatory Agents; Gastritis; Gene Expression; Histamine Antagonists; Humans; Lipopo | 2020 |
Enhanced therapeutic response with addition of loratadine in subserosal eosinophilic gastroenteritis.
Topics: Anti-Allergic Agents; Ascites; Biomarkers; Drug Therapy, Combination; Enteritis; Eosinophilia; Eosin | 2013 |